Rocket Pharmaceuticals (RCKT) Earnings (2014 - 2026)
Rocket Pharmaceuticals (RCKT) earnings from Mar 31, 2014 to Mar 31, 2026. The TTM Rocket Pharmaceuticals (RCKT) earnings is -$209M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Rocket Pharmaceuticals (RCKT) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -18.85% |
| 3 Years TTM | -4.07% |
| 5 Years TTM | +6.17% |
| 10 Years TTM | +10.58% |
| All Time TTM | +33.32% |
Annual Earnings change of Rocket Pharmaceuticals (RCKT)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$48M | -78.67% |
| 2025 | -$223M | -13.77% |
| 2024 | -$259M | +5.36% |
| 2023 | -$246M | +10.70% |
| 2022 | -$222M | +31.22% |
| 2021 | -$169M | +21.02% |
| 2020 | -$140M | +80.79% |
| 2019 | -$77M | +3.69% |
| 2018 | -$75M | +280.59% |
| 2017 | -$20M | +158.65% |
| 2016 | -$7.57M | -88.86% |
| 2015 | -$68M | +613.33% |
| 2014 | -$9.53M | N/A |
Comparison Rocket Pharmaceuticals (RCKT) five years earnings CAGR with competitors
Rocket Pharmaceuticals (RCKT) five years earnings CAGR is 6.17%.